Financial Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences Share by Ken Dropiewski on January 22, 2019 More in Financial: SCAI and CRT Announce Partnership to Advance Interventional Cardiology Education, Advocacy, and Research December 2, 2025 Procyrion Appoints Andrew Davis as Chief Commercial Officer December 2, 2025 Xeltis secures nearly €50m from the European Investment Bank (EIB) and existing shareholders to advance aXess, its vascular access conduit to the market December 2, 2025 Share this story Facebook Twitter LinkedIn